FMA
DGX icon

FNY Managed Accounts’s Quest Diagnostics DGX Stock Holding History

FNY Managed Accounts’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$10K Buy
108
+40
+59% +$4.1K 0.01% 130
2017
Q4 		$6K Sell
68
-204
-75% -$19.3K 0.01% 281
2017
Q3 		$25K Buy
272
+137
+101% +$14.5K 0.03% 300
2017
Q2 		$15K Sell
135
-40
-23% -$4.23K 0.15% 89
2017
Q1 		$17K Buy
+175
New +$16.7K 0.05% 377

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FNY Managed Accounts's DGX Position: Q1 2018 in Review

FNY Managed Accounts increased its Quest Diagnostics (DGX) stake by 59% in Q1 2018, buying an estimated $4.1K and bringing the position to 108 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #130.

FNY Managed Accounts first reported a position in DGX in Q1 2017 and has held it in 5 quarters since. The position peaked at $25K in Q3 2017. 652 funds tracked by Wall St. Rank hold DGX as of Q1 2018.

  • FNY Managed Accounts held 108 shares of Quest Diagnostics worth $10K as of Q1 2018.
  • FNY Managed Accounts bought 40 Quest Diagnostics shares in Q1 2018, an estimated $4.1K.
  • Quest Diagnostics made up 0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #130 holding.
  • FNY Managed Accounts first reported a position in Quest Diagnostics in Q1 2017 and has held it in 5 quarters since.
  • FNY Managed Accounts's Quest Diagnostics position peaked at $25K in Q3 2017.
  • 652 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.